| http://www.w3.org/ns/prov#value | - cal and other risks including interest rate and exchange rate risks related to conducting business internationally; our ability to successfully operate new lines of business; our a http://www.bio-medicine.org/inc/biomed/medicine-technology.asp http://feeds.bio-medicine.org/latest-medical-technologyDate:9/18/2013 om changes in the reimbursement policies of third-party payers; our ability to grow ou
|
